Got a new idea?   |   PMR Publications   |   PMR Consulting   |   PMR Research   |   PMR Online Access
 


 

Hungarian Health Insurance Fund’s deficit lower than expected in 2009


2010-02-23

The deficit of Hungary’s National Health Insurance Fund (OEP) reached the amount of nearly HUF 150bn (€551.4m) in 2009 and thus was lower than previously forecast by the government. The vast majority of the deficit, HUF 138bn (€507.3m), was caused by the fact that in 2009 less funds than expected were received from health insurance premiums and medical services premiums. The OEP’s budget was also negatively impacted by the exceeding of expenses on medical and preventive funding amounting to HUF 14bn (€51.5m) last year. Also the fact that the government had frozen the amount of HUF 13bn (€47.8m) in the budget at the beginning of last year influenced the situation in a negative way.

On the other hand, the deficit was partly compensated by the fact that drug manufacturers paid HUF 8bn (€29.4) more to the health insurance budget then previously estimated.
However, in December, the OEP’s budget regained its balance, thanks in part to re-introducing the restrictions on the number of procedures performed by the hospitals, which were forced to hold in their performance and overall spent HUF 54bn (€198.5) from the total HUF 60bn (€220.6m) available. The other positive factor to be mentioned is the fact that the hospitals received an additional HUF 4.5bn (€16.5m) released from the amount previously frozen by the government.


Browse and search in our archive »


subscribe to PMR RSS NEWS channelsSubscribe to PMR RSS NEWS channels »




PMR publications >> Pharma



Online access:





Central Europe Pharma Online [EN]

1 year subscription to internet service providing market news and analytical articles


Central Europe Pharma Online provides news, articles and market data on the pharmaceutical market in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, from manufacturers and distributors to medical devices and research developments. Over 70 industry updates, covering manufacturers and distributors, medical news and research developments, together with news on laws and regulations governing the pharmaceutical sector are added on a regular basis. For timely news delivery, custom newsletters can be sent directly to your e-mail account, with content personalisation.
Subscription 1 year
Language: English
Delivery: online access



description leaflet buy now add to basket request more info




Newsletters:





Central Europe Pharma News [EN]

12-month subscription (26 issues of biweekly news)


Central Europe Pharma News is a bi-weekly newsletter delivered in PDF format directly to your inbox. Each edition of the newsletter delivers news and analysis of the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, including an in-depth feature on the pharmaceutical industry in the Central & Eastern Europe region written by PMR market analysts. A list of upcoming events relevant to the region and a company index are included in every issue.
Date: Periodic publication
Language: English
Delivery: PDF file



description sample issue buy now add to basket request more info


 
About us         Contact us         Privacy Policy
Copyright © 2012 PMR. All rights reserved.

PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.